Pearle Vision 1 day (Somofilcon A) Contact Lens
Some Pearle Vision 1 day contact lenses have the incorrect power.
Moderate risk
Using it may cause temporary or medically reversible health problems. Serious harm is unlikely.
FDA Class II recall · How risk is rated
What happened
CooperVision, Inc., of West Henrietta, New York, began a recall of Pearle Vision 1 day (somofilcon A) Contact Lenses on August 12, 2026, because a small number of lenses within the affected lot are of the incorrect power. The recall was added to the FDA's Enforcement Report and classified on September 18, 2026. The product was distributed nationwide in the states of Minnesota, Ohio and Wisconsin.
Summary by Recall Canary from the FDA notice.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is yours affected?
Match the UDI-DI and lot code listed under your product.
Pearle Vision 1 day (somofilcon A) Contact Lens
- UDI-DI
- 11727620152030
- Lot
- CB132348
Details
- Company began the recall
- Event ID
- 99766
- Recall No.
- Z-3248-2026
- Company
- CooperVision, Inc.West Henrietta, New York
- Hazard
- Device defect
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
